TriSalus Life Sciences (TLSIW) Other Non-Current Liabilities (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Other Non-Current Liabilities data on file, last reported at $9.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 10.39% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 10.39% YoY), and the FY2025 full-year result was $10.1 million, up 37.06% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $9.1 million, down from $10.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $18.6 million in Q4 2023 and bottomed at $369000.0 in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $8.0 million (2024), against an average of $8.6 million.
• The widest annual swing landed in 2023, when Other Non-Current Liabilities jumped 4949.32%; it then slumped 60.28% in 2024.
• A 5-year view of Other Non-Current Liabilities shows it stood at $369000.0 in 2022, then surged by 4949.32% to $18.6 million in 2023, then plunged by 60.28% to $7.4 million in 2024, then surged by 37.06% to $10.1 million in 2025, then decreased by 10.54% to $9.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $9.1 million (Q1 2026), $10.1 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.

Peer Comparison